Taiwan · Delayed Price · Currency is TWD MARX Biotech Statistics
Total Valuation
MARX Biotech has a market cap or net worth of TWD 2.30 billion. The enterprise value is 2.65 billion.
| Market Cap | 2.30B |
| Enterprise Value | 2.65B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MARX Biotech has 505.98 million shares outstanding. The number of shares has increased by 31.29% in one year.
| Current Share Class | 505.98M |
| Shares Outstanding | 505.98M |
| Shares Change (YoY) | +31.29% |
| Shares Change (QoQ) | +1.41% |
| Owned by Insiders (%) | 22.96% |
| Owned by Institutions (%) | n/a |
| Float | 322.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.23 |
| PB Ratio | 10.77 |
| P/TBV Ratio | 19.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -31.90 |
| EV / Sales | 3.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.43 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 1.74.
| Current Ratio | 1.16 |
| Quick Ratio | 0.37 |
| Debt / Equity | 1.74 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.05 |
| Interest Coverage | -8.53 |
Financial Efficiency
Return on equity (ROE) is -36.09% and return on invested capital (ROIC) is -10.93%.
| Return on Equity (ROE) | -36.09% |
| Return on Assets (ROA) | -8.02% |
| Return on Invested Capital (ROIC) | -10.93% |
| Return on Capital Employed (ROCE) | -18.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 80 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 1.32 |
Taxes
| Income Tax | -3.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -35.00% |
| 50-Day Moving Average | 4.64 |
| 200-Day Moving Average | 5.32 |
| Relative Strength Index (RSI) | 41.35 |
| Average Volume (20 Days) | 1,925,389 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MARX Biotech had revenue of TWD 712.87 million and -83.01 million in losses. Loss per share was -0.17.
| Revenue | 712.87M |
| Gross Profit | 485.67M |
| Operating Income | -73.53M |
| Pretax Income | -86.11M |
| Net Income | -83.01M |
| EBITDA | -57.30M |
| EBIT | -73.53M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 27.46 million in cash and 373.00 million in debt, giving a net cash position of -345.55 million or -0.68 per share.
| Cash & Cash Equivalents | 27.46M |
| Total Debt | 373.00M |
| Net Cash | -345.55M |
| Net Cash Per Share | -0.68 |
| Equity (Book Value) | 213.80M |
| Book Value Per Share | 0.42 |
| Working Capital | 53.98M |
Cash Flow
In the last 12 months, operating cash flow was -145.67 million and capital expenditures -210.49 million, giving a free cash flow of -356.16 million.
| Operating Cash Flow | -145.67M |
| Capital Expenditures | -210.49M |
| Free Cash Flow | -356.16M |
| FCF Per Share | -0.70 |
Margins
Gross margin is 68.13%, with operating and profit margins of -10.31% and -11.64%.
| Gross Margin | 68.13% |
| Operating Margin | -10.31% |
| Pretax Margin | -12.08% |
| Profit Margin | -11.64% |
| EBITDA Margin | -8.04% |
| EBIT Margin | -10.31% |
| FCF Margin | n/a |
Dividends & Yields
MARX Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.29% |
| Shareholder Yield | -31.29% |
| Earnings Yield | -3.61% |
| FCF Yield | -15.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2024. It was a forward split with a ratio of 2.
| Last Split Date | Jul 11, 2024 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
MARX Biotech has an Altman Z-Score of 5.12 and a Piotroski F-Score of 1.
| Altman Z-Score | 5.12 |
| Piotroski F-Score | 1 |